Concepedia

Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits

C Coscelli, Gianluca Iacobellis, C Calderini, R Carleo, Marina Guimarães Gobbo, Umberto Di Mario, Frida Leonetti, Aldo Galluzzo, V. Pirrone, M Lunetta,

Acta Diabetologica · 2003 · 25 citations · 7 references

DOI

Concepts

References

7

Nonfasting Plasma Glucose is a Better Marker of Diabetic Control Than Fasting Plasma Glucose in Type 2 Diabetes

A. Avignon, Anca Radauceanu, Louis Monnier · Diabetes Care · 1997 · 366 citations

, , +17

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

Edward J. Bastyr, CA Stuart, Robert G. Brodows et al. · Diabetes Care · 2000 · 275 citations · Full text

, , +17

Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Humalog Mix25 Study Group.

Paris Roach, Vipin Arora · Diabetes Care · 1999 · 109 citations

, , +15

Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin

Tim Heise, Christian Weyer, Andreas Serwas et al. · Diabetes Care · 1998 · 109 citations

, , +13

Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50

Paris Roach, Michael Trautmann, Vipin Arora et al. · Clinical Therapeutics · 1999 · 80 citations

, , +13